Results 121 to 130 of about 31,199 (226)

Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data [PDF]

, 2018
Aims To evaluate the cost-effectiveness of Age-Related Eye Disease Study (AREDS) 1 & 2 supplements in patients with either bilateral intermediate age-related macular degeneration, AREDS category 3, or unilateral neovascular age-related macular ...
Agron, E, Butt, T, Chew, E, Clemons, TE, Egan, CA, Lee, AY, Lee, CS, Tufail, A   +7 more
core  

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

Pharmaceuticals
Background: Age-related macular degeneration (AMD) is the leading cause of vision loss in elderly people. Current pharmacological treatment in vascular AMD includes anti-VEGF agents, such as ranibizumab and aflibercept. Additionally, the off-label use of
João Estarreja, Priscila Mendes, Carina Silva, Pedro Camacho, Vanessa Mateus   +4 more
doaj   +1 more source

Ocular syphilis masquerading as refractory retinal diseases

BMC Infectious Diseases
Purpose To report two cases of syphilis masquerading as chronic refractory macular diseases. Case descriptions Two patients had been diagnosed with neovascular age-related macular degeneration (neovascular AMD) and diabetic macular edema (DME ...
Sung Who Park, Kye-Hyung Kim, Han Jo Kwon, Ik Soo Byon, Youan Hasan Khan, Quan Dong Nguyen   +5 more
doaj   +1 more source

Acute onset of neovascular age-related macular degeneration after initiation of tirzepatide. [PDF]

Diabetol Int
Takebayashi K, Iemura Y, Yamauchi M, Hara K, Tsuchiya T, Machida S, Hashimoto K.   +6 more
europepmc   +1 more source

Draft a protocol for an observational study for anti-VEGF therapy in age related macular degeneration [PDF]

, 2015
Μακρή, Όλγα
core   +1 more source

Relative Risk of Neovascular Age-Related Macular Degeneration Following Cataract Surgery. [PDF]

JAMA Ophthalmol
Bellanda V, Schulgit MJ, Barbosa GCS, Mohan N, Arline A, Bala S, Kaelber DC, Srivastava SK, Sharma S.   +8 more
europepmc   +1 more source

Imaging and functional correlates of fibrosis in neovascular age-related macular degeneration: a systematic review. [PDF]

Front Ophthalmol (Lausanne)
Spooner KL, Fraser-Bell S, Fu DJ, Faes L, Romano F, Cozzi M, Chang AA, Sivaprasad S.   +7 more
europepmc   +1 more source

Management of fibrosis in neovascular age-related macular degeneration. [PDF]

Graefes Arch Clin Exp Ophthalmol
Chakravarthy U, Foss AJE, Panos GD, Peto T, Rotsos T, Sadda S, De Cock E, Empeslidis T.   +7 more
europepmc   +1 more source

Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration. [PDF]

PLoS One
Iby J, Coulibaly L, Hollaus M, Yeghiazaryan L, Schmidt-Erfurth U, Bühl W, Sacu S.   +6 more
europepmc   +1 more source

Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit. [PDF]

Br J Ophthalmol
Jaggi D, Marugg S, Berger LE, Munk MR, Zinkernagel MS, Heussen FM.   +5 more
europepmc   +1 more source